BioMarin Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,242	3,221	2,854	2,419	2,096	1,846
Revenue Growth (YoY)	9.90%	12.87%	17.97%	15.42%	13.53%	-0.76%
Cost of Revenue	760.88	717.44	580.24	532.06	503.02	470.52
Gross Profit	2,481	2,504	2,274	1,887	1,593	1,376
Selling, General & Admin	1,205	1,153	1,009	892.41	823.24	759.38
Depreciation & Amortization Expenses	19.02	19.39	43.26	62.21	67.19	69.93
Research & Development	942	921.93	747.18	746.77	649.61	628.79
Other Operating Expenses	-	-	-10	-	-108	-
Total Operating Expenses	2,166	2,094	1,789	1,701	1,432	1,458
Operating Income	315.23	409.48	484.21	185.77	160.97	-82.34
Interest Income	78.45	74.9	74.88	58.34	18.03	10.48
Interest Expense	-22.99	-10.9	-12.67	-17.34	-15.97	-15.34
Other Non-Operating Income (Expense)	14.91	9	-4.67	-38.22	-13.46	11.85
Total Non-Operating Income (Expense)	70.37	73	57.55	2.79	-11.4	6.99
Pretax Income	385.59	482.48	541.76	188.56	149.58	-75.35
Provision for Income Taxes	116.85	133.58	114.9	20.92	8.02	-11.27
Net Income	268.74	348.9	426.86	167.65	141.56	-64.08
Net Income to Common	268.74	348.9	426.86	167.65	141.56	-64.08
Net Income Growth	-48.70%	-18.26%	154.62%	18.43%	-	-
Shares Outstanding (Basic)	192	192	190	188	185	183
Shares Outstanding (Diluted)	195	197	197	192	189	183
Shares Change (YoY)	-1.48%	0.35%	2.67%	1.39%	3.34%	-4.61%
EPS (Basic)	1.40	1.82	2.25	0.89	0.76	-0.35
EPS (Diluted)	1.37	1.80	2.21	0.87	0.75	-0.35
EPS Growth	-49.07%	-18.55%	154.02%	16.00%	-	-
Shares Outstanding	193.27	192.3	190.76	188.6	186.25	183.91
Free Cash Flow	767.06	724.96	487.42	62.57	54.94	208.96
Free Cash Flow Growth	5.81%	48.73%	679.02%	13.88%	-73.71%	-
Free Cash Flow Per Share	3.94	3.67	2.48	0.33	0.29	1.14
Gross Margin	76.53%	77.73%	79.67%	78.01%	76.00%	74.52%
Operating Margin	9.72%	12.71%	16.97%	7.68%	7.68%	-4.46%
Profit Margin	8.29%	10.83%	14.96%	6.93%	6.75%	-3.47%
FCF Margin	23.66%	22.51%	17.08%	2.59%	2.62%	11.32%
EBITDA	389.12	489.04	580.64	290.16	262.94	25.7
EBITDA Margin	12.00%	15.18%	20.35%	11.99%	12.54%	1.39%
EBIT	315.23	409.48	484.21	185.77	160.97	-82.34
EBIT Margin	9.72%	12.71%	16.97%	7.68%	7.68%	-4.46%
Effective Tax Rate	30.30%	27.69%	21.21%	11.09%	5.36%	14.96%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q